J Bone Jt Infect 2020; 5(2):101-105. doi:10.7150/jbji.42079

Research Paper

Wound Complications after 2-Octyl Skin Closure Systems for Total Joint Arthroplasty

Andrew Michalowitz, Robert Comrie, Christopher Nicholas, Michael Wagner, James Kehoe

McLaren Macomb Hospital

This is an open access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/). See http://ivyspring.com/terms for full terms and conditions.
Citation:
Michalowitz A, Comrie R, Nicholas C, Wagner M, Kehoe J. Wound Complications after 2-Octyl Skin Closure Systems for Total Joint Arthroplasty. J Bone Jt Infect 2020; 5(2):101-105. doi:10.7150/jbji.42079. Available from http://www.jbji.net/v05p0101.htm

File import instruction

Abstract

Introduction: Total joint arthroplasty is projected to expand rapidly by 2030. With large numbers of patients undergoing TJA, the choice of incisional closure has come into question. We compared the 2-Ocyl cyanoacrylate closure system of Dermabond ® Prineo ® with Exofin Fusion ® to compare rates of adverse wound outcomes after total joint arthroplasty. Secondary outcome measures were age, sex, and medical comorbidities between groups.

Methods: We retrospectively reviewed adverse wound outcomes with skin closure in TJA in 281 patients (160 Dermabond Prineo and 121 Exofin Fusion). Clinical charts were analyzed out to the 6-week post-op visit.

Results: The rate of overall adverse superficial wound outcomes was similar between the two groups with Dermabond Prineo (N=20) and Exofin Fusion (N=19). The rate of cellulitis was significantly higher for Dermabond Prineo when compared to Exofin Fusion (P=0.033). No other significant differences were found for rate of superficial or deep wound complications or for secondary outcomes.

Conclusions: The two 2-octyl wound closure systems had similar adverse superficial wound complications. Except for Dermabond Prineo having a higher rate of post-operative cellulitis, there were no statistically significant differences for other superficial or deep adverse wound outcomes or secondary outcomes. A future randomized control trial or prospective cohort study is needed for a more robust analysis.

Keywords: 2-cyanoacrylate, 2-octyl, Dermabond, Prineo, Exofin, total joint arthroplasty, dermatitis, superficial infection